Richard Nolan Townsend Lexeo Therapeutics, Inc. (LXEO) insider trading activity

LXEO Quotes by TradingView
Shares Held (Direct Ownership) 121K
0% 3M change
n/a 12M change
Total Value Held N/A

Richard Nolan Townsend Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2024
SELL
Open market or private sale
$20,500 $8.2 p/Share
2,500 Reduced 2.03%
120,695 Common Stock
Dec 10 2024
BUY
Exercise of conversion of derivative security
$5,825 $2.33 p/Share
2,500 Added 1.99%
123,195 Common Stock
Nov 11 2024
SELL
Open market or private sale
$19,550 $7.82 p/Share
2,500 Reduced 2.03%
120,695 Common Stock
Nov 11 2024
BUY
Exercise of conversion of derivative security
$5,825 $2.33 p/Share
2,500 Added 1.99%
123,195 Common Stock
Oct 10 2024
SELL
Open market or private sale
$40,500 $8.1 p/Share
5,000 Reduced 3.98%
120,695 Common Stock
Oct 10 2024
BUY
Exercise of conversion of derivative security
$11,650 $2.33 p/Share
5,000 Added 3.83%
125,695 Common Stock
Sep 10 2024
SELL
Open market or private sale
$53,250 $10.65 p/Share
5,000 Reduced 3.98%
120,695 Common Stock
Sep 10 2024
BUY
Exercise of conversion of derivative security
$11,650 $2.33 p/Share
5,000 Added 3.83%
125,695 Common Stock
Aug 12 2024
SELL
Open market or private sale
$57,650 $11.53 p/Share
5,000 Reduced 3.98%
120,695 Common Stock
Aug 12 2024
BUY
Exercise of conversion of derivative security
$11,650 $2.33 p/Share
5,000 Added 3.83%
125,695 Common Stock
Jul 11 2024
SELL
Open market or private sale
$506,239 $18.06 p/Share
28,031 Reduced 18.85%
120,695 Common Stock
Jul 10 2024
SELL
Open market or private sale
$449,033 $16.65 p/Share
26,969 Reduced 15.35%
148,726 Common Stock
Jul 10 2024
BUY
Exercise of conversion of derivative security
$11,650 $2.33 p/Share
5,000 Added 2.77%
175,695 Common Stock
Jun 10 2024
SELL
Open market or private sale
$88,699 $17.74 p/Share
5,000 Reduced 2.85%
170,695 Common Stock
Jun 10 2024
BUY
Exercise of conversion of derivative security
$11,650 $2.33 p/Share
5,000 Added 2.77%
175,695 Common Stock
May 13 2024
SELL
Open market or private sale
$66,100 $13.22 p/Share
5,000 Reduced 2.85%
170,695 Common Stock
May 13 2024
BUY
Exercise of conversion of derivative security
$11,650 $2.33 p/Share
5,000 Added 2.77%
175,695 Common Stock
Jan 05 2024
BUY
Grant, award, or other acquisition
-
43,750 Added 20.4%
170,695 Common Stock
RNT

Richard Nolan Townsend

Chief Executive Officer
New York, NY

Track Institutional and Insider Activities on LXEO

Follow Lexeo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXEO shares.

Notify only if

Insider Trading

Get notified when an Lexeo Therapeutics, Inc. insider buys or sells LXEO shares.

Notify only if

News

Receive news related to Lexeo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LXEO